Liewei Wang Selected Research

Cytidine

2/2014	Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines.
2/2011	Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination.
6/2010	Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach.
11/2009	Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.
9/2008	Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liewei Wang Research Topics

Disease

69	Neoplasms (Cancer) 06/2022 - 09/2008
66	Breast Neoplasms (Breast Cancer) 06/2022 - 12/2005
15	Major Depressive Disorder (Major Depressive Disorders) 11/2022 - 03/2013
14	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2015
12	Triple Negative Breast Neoplasms 06/2022 - 11/2016
9	Drug-Related Side Effects and Adverse Reactions 02/2021 - 09/2003
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2015
6	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016 - 06/2010
5	Lung Neoplasms (Lung Cancer) 01/2021 - 06/2011
4	Stroke (Strokes) 01/2020 - 01/2011
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021 - 01/2019
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2018
3	Myocardial Infarction 01/2020 - 01/2011
3	T-Cell Leukemia (Leukemia, T Cell) 01/2018 - 03/2012
3	Leukemia 09/2017 - 01/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012 - 06/2011
3	Carcinogenesis 08/2011 - 03/2006
2	Rheumatoid Arthritis 01/2022 - 01/2022
2	Multiple Myeloma 01/2021 - 06/2008
2	Thrombosis (Thrombus) 01/2021 - 01/2020
2	Hemorrhage 01/2020 - 01/2020
2	Inflammation (Inflammations) 01/2019 - 01/2017
2	Circulating Neoplastic Cells 01/2018 - 08/2017
2	Pathologic Complete Response 01/2018 - 01/2017
2	Musculoskeletal Pain 03/2016 - 03/2012
2	Adenocarcinoma 02/2016 - 01/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2014 - 12/2010
1	Fatigue 11/2022

Drug/Important Bio-Agent (IBA)

29	Pharmaceutical PreparationsIBA 06/2022 - 09/2004
17	Aromatase InhibitorsIBA 10/2021 - 12/2005
17	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2008
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
14	Estrogens (Estrogen)FDA Link 01/2022 - 12/2005
13	Estrogen ReceptorsIBA 01/2021 - 04/2013
11	Gemcitabine FDA Link 12/2016 - 09/2008
10	Small Interfering RNA (siRNA)IBA 12/2016 - 11/2009
9	Anastrozole (Arimidex)FDA LinkGeneric 01/2022 - 01/2010
8	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2011
7	Biological ProductsIBA 06/2022 - 06/2011
7	Androgen Receptors (Androgen Receptor)IBA 06/2022 - 01/2017
7	RNA (Ribonucleic Acid)IBA 03/2019 - 12/2014
6	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021 - 03/2013
6	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2015
5	Phenobarbital (Luminal)FDA Link 06/2022 - 01/2017
5	exemestane (Aromasin)FDA Link 01/2022 - 12/2016
5	Aromatase (CYP19)IBA 01/2020 - 12/2005
5	Estradiol (Delestrogen)FDA LinkGeneric 01/2020 - 01/2010
5	Selective Estrogen Receptor Modulators (SERM)IBA 08/2017 - 07/2013
5	CytidineIBA 02/2014 - 09/2008
4	abirateroneIBA 01/2022 - 08/2017
4	AnthracyclinesIBA 01/2022 - 12/2017
4	Trastuzumab (Herceptin)FDA Link 01/2022 - 12/2017
4	Antidepressive Agents (Antidepressants)IBA 10/2021 - 08/2018
4	Phosphotransferases (Kinase)IBA 01/2021 - 12/2018
4	AndrogensIBA 01/2021 - 01/2015
4	taxaneIBA 01/2021 - 09/2012
4	Tamoxifen FDA LinkGeneric 01/2021 - 07/2013
4	Bevacizumab (Avastin)FDA Link 01/2018 - 01/2012
4	P-2 (P 2)IBA 10/2017 - 07/2013
3	Long Noncoding RNAIBA 12/2021 - 12/2016
3	Docetaxel (Taxotere)FDA Link 01/2021 - 09/2012
3	enzalutamideIBA 01/2021 - 01/2015
3	Abiraterone AcetateIBA 12/2020 - 08/2017
3	Estrone FDA Link 01/2020 - 01/2010
3	EnzymesIBA 01/2019 - 12/2005
3	Cisplatin (Platino)FDA LinkGeneric 12/2018 - 09/2011
3	olaparibIBA 12/2018 - 01/2017
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 01/2015
3	Messenger RNA (mRNA)IBA 11/2017 - 12/2014
3	2-mercaptopurineIBA 03/2014 - 09/2003
2	Letrozole (Femara)FDA LinkGeneric 01/2022 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2022
2	GlucocorticoidsIBA 12/2021 - 01/2018
2	Clopidogrel (Plavix)FDA Link 01/2021 - 01/2020
2	Cytochrome P-450 CYP2C19IBA 01/2021 - 01/2020
2	Aurora Kinase AIBA 01/2021 - 01/2018
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 12/2018
2	Prednisone (Sone)FDA LinkGeneric 12/2020 - 01/2018
2	LigandsIBA 01/2020 - 08/2017
2	Therapeutic UsesIBA 11/2019 - 09/2008
2	MethyltransferasesIBA 11/2019 - 01/2018
2	Nucleic AcidsIBA 03/2019 - 09/2008
2	Escitalopram FDA Link 01/2019 - 01/2019
2	Citalopram FDA LinkGeneric 01/2019 - 01/2019
2	Protein Kinases (Protein Kinase)IBA 01/2018 - 01/2015
2	Estrogen Receptor alphaIBA 01/2018 - 01/2017
2	HomocysteineIBA 01/2018 - 03/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2017 - 09/2012
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2015 - 10/2015
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2015 - 07/2013
1	Fluoxetine (Prozac)FDA LinkGeneric 11/2022
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 11/2022
1	AMP-Activated Protein KinasesIBA 06/2022

Therapy/Procedure

48	Therapeutics 06/2022 - 01/2010
33	Drug Therapy (Chemotherapy) 01/2022 - 09/2004
12	Neoadjuvant Therapy 06/2022 - 01/2010
9	Castration 01/2022 - 08/2017
3	Radiotherapy 01/2021 - 11/2010
3	Precision Medicine 12/2018 - 01/2015
2	Stents 01/2021 - 01/2020